Breaking News
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
F1 Oncology Expands Operations
International affiliate, Exuma Biotechnology, acquires CAR-T assets11.15.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Process Development
Goodwin Bio, Radimmune Enter Oncology Pact
Radimmune selected Goodwin for process development through cGMP manufacturing of their IgG mAb conjugate11.15.18
-
Breaking News | Cold Chain Management | Facilities | Industry News
PCI Expands Clinical Services Biz
Rockford, IL Center of Excellence to add 30,000 additional sq. ft. of space11.15.18
-
Breaking News | Industry News
Sandoz Recalls Lot of Losartan
API contained an impurity, N-nitrosodiethylamine, a probable human carcinogen11.14.18
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
DNAtrix, Valo Therapeutics Enter Strategic R&D Pact
To combine DNAtrix's oncolytic adenovirus platform and Valo's PeptiCRAd vaccination technology for "armed oncolytic vaccine"11.14.18
-
Breaking News | Industry News | Toxicology
Lonza Endotoxin Expert Appointed Chair of ASMFC Horseshoe Crab Panel
Burgenson elected to position in recognition of more than 35 years of experience in the biomedical use of horseshoe crabs11.14.18
-
Breaking News | Drug Discovery | Industry News | Laboratory Testing
Vector Labs Attains ISO 9001:2015 Certification
Designation certifies a high level of quality assurance and consistency for research in pharmaceutical discovery11.14.18
-
Breaking News | Drug Development | Drug Discovery | Industry News
Celgene, Dragonfly Expand Immunotherapy Alliance
Celgene has the option to license exclusive rights to products using Dragonfly's TriNKET platform for four new targets11.14.18
-
Breaking News | Industry News | Information Technology | Packaging & Tracking | Serialization
GS1 US Launches EPCIS Conformance Testing Program
Drummond Group certified as first conformance testing service11.13.18
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
Enable Injections Partners with UCB and Apellis Pharmaceuticals
Patient-centric drug delivery important for treatment adherence, commercial success11.13.18
-
Analytical Services | Breaking News | Industry News | Laboratory Testing
SGS Expands Elemental Impurity Testing Services
Makes investment at its laboratory in Chennai, India11.13.18
-
Breaking News | Industry News
-
Breaking News | Clinical Trial Materials | Industry News
Catalent to Open Second Clinical Supply Facility in China
Enables broader integrated solutions for global and local customers11.13.18
-
Breaking News | Clinical Trials | Collaborations & Alliances | CRO News | Information Technology
SHYFT Analytics, PAREXEL Enter Strategic RWE Pact
Will leverage SHYFT’s technology for Real-World Evidence generation and outcomes research11.12.18
-
Breaking News | Promotions & Moves
Pharma Tech Industries Hires Senior QC Professionals
Harward and Weingart bring extensive pharmaceutical industry experience11.12.18
-
Breaking News | Collaborations & Alliances | R&D
BridgeBio Pharma Enters Genetic Disease Alliance
Research collaboration aims to identify and develop genetic disease therapies11.12.18
-
Breaking News | CRO News | Drug Development | Industry News
CMIC Details Services & Growth
Company executives Lucy Sha and Mike Suga spoke with Contract Pharma at AAPS 2018 about CMIC's history, growth & capabilitiesVideos
-
Breaking News | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Ziopharm, Regeneron In Clinical Supply Pact
Will evaluate Ziopharm’s Ad-RTS-hIL-12 plus veledimex with Regeneron’s PD-1 antibody Libtayo in recurrent glioblastoma11.12.18
-
Breaking News | Industry News | Serialization
Metrics Provides Serialization at Greenville Site
Completes qualification of two commercial bottling lines for serialization11.12.18
-
Bio News | Breaking News | CRO News | Drug Development | Industry News | Laboratory Testing | R&D
PPD Discusses Lab Trends
Heather Myler, Director R&D, Immunochemistry, PPD discusses trends, including the increase of new modalities in the industryVideos
